BioSpace News Archive

Press Releases

Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

March 31, 2026
·
9 min read
Press Releases

ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy Pipeline

March 31, 2026
·
7 min read
Press Releases

CellCentric Initiates DOMMINO-1, a Pivotal Phase 2 Clinical Trial of Inobrodib in Combination with Pomalidomide and Dexamethasone (InoPd) in Relapsed or Refractory Multiple Myeloma

March 31, 2026
·
4 min read
Press Releases

Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results

March 31, 2026
·
10 min read
Press Releases

AN2 Therapeutics Announces Initiation of Phase 2 Investigator-Initiated Clinical Trial of Epetraborole for Mycobacterium abscessus Complex Lung Disease

March 31, 2026
·
5 min read
Press Releases

Poxel Announces the Sale of PXL770 to Scynexis for a Total Amount of up to $196 Million

March 31, 2026
·
5 min read
Press Releases

Scala Biodesign Raises $16M Series A Financing to Accelerate Development of Protein-Based Products with ScalaOS

March 31, 2026
·
4 min read
Press Releases

TippingPoint Biosciences Raises $4.5M Seed to Drug Hidden Epigenetic Targets in Deadly Pediatric Brain Cancer

March 31, 2026
·
3 min read
Press Releases

Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

March 31, 2026
·
15 min read
Press Releases

Catheter Precision Reports 2025 Results and Updates on Strategic Expansion

March 31, 2026
·
11 min read